Mesothelioma is a rare and devastating form of cancer caused primarily by asbestos exposure. It mostly attacks the lungs. Not much more is understood about mesothelioma, and for that reason every bit of information available is extremely important.
In this video shared by OncLiveTV, a panel of physicians discuss the potential for checkpoint inhibitors such as pembrolizumab for malignant pleural mesothelioma. The panel also discusses the undisputed importance of clinical trials for new potential medicines.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.